Me Too!

The long term management of COPD has been affected by the latest “me-too” drug to be announced.  Until now the only long-acting anti-muscarinic drug available was tioptropium. Until now, Boehringer-Ingelheim have had this important field to …

Read More

Full of (Kidney) Beans!

People interested in diabetes are always talking about eyes, feet or kidneys. At the present time, the interest is in kidneys. That’s not to say that eyes and feet have taken a back seat. It’s just …

Read More

Where there’s a pill, there’s a way

If everything in medicine were cut and dried, it wouldn’t be nearly as interesting a profession. A recent article in the Daily Telegraph highlighted a real dilemma that often faces clinical staff today. We live in …

Read More

Trial & Error

The recent impact of the long trial on the benefits of HRT has again rasied the whole  question of clinical trials. The report: “Schierbeck LL, Rejnmark L, Tofteng CL et al, Effect of hormone replacement therapy …

Read More

United Statins?

Years ago someone produced a facetious (and fictional) history of a new drug.  It went something like this. 1.    New drug announced (“must try it” say all the whizz GP’s) 2.    Drug cures everything (No 1 …

Read More

The Price Is Right?

Oh, is it that time of the year again ?  Yes, it’s Polypill time again. It is nearly a decade since we first started hearing about the polypill as a preventative of cardiovascular disease.  Since then, …

Read More